diazoxide has been researched along with cysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Babes, A; Engel, MA; Filipovic, M; Fischer, MJ; Flonta, ML; Reeh, PW | 1 |
1 review(s) available for diazoxide and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for diazoxide and cysteine
| Article | Year |
|---|---|
The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel.
Topics: Acetanilides; Animals; Calcium; Calcium Channels; Cells, Cultured; Cysteine; Diazoxide; Ganglia, Spinal; Glyburide; HEK293 Cells; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Purines; Recombinant Proteins; Sensory Receptor Cells; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2013 |